The impact of hydrogen-rich water on liver enzyme levels in clinical populations: a comprehensive review and meta-analysis.
Ghazaleh Khalili-Tanha, Hamid Jamialahmadi, Mostafa Rezaei-Tavirani, Elham Nazari · Gastroenterology and hepatology from bed to bench · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This meta-analysis examined the available evidence on molecular hydrogen. The results showed a slight decrease in ALT, AST, and ALP levels in the treated group with HRW compared to the PW group. The reviewed evidence supports molecular hydrogen's therapeutic potential. Additional well-designed studies are needed to clarify clinical safety and effectiveness.
What the Review Examined
The review examined recent studies have shown the prospective therapeutic advantages of hydrogen as an antioxidant and anti-inflammatory agent in many circumstances.
Main Findings Across the Literature
The results showed a slight decrease in ALT, AST, and ALP levels in the treated group with HRW compared to the PW group.
Authors’ Conclusion
The authors concluded that consuming HRW may decrease liver enzyme levels in clinical populations. Further research is needed to confirm this relationship.